Complications impaired endothelial progenitor cell function in Type 2 diabetic patients with or without critical leg ischaemia: Implication for impaired neovascularization in diabetes: Original Article: Complications

Diabetic Medicine

Volumn 26, Issue 2, 2009, Pages 134-141

  Chen, M C ^a,b   Sheu, J J ^c   Wang, P W ^a   Chen, C Y ^a   Kuo, M C ^a   Hsieh, C J ^a   Chen, J F ^a   Chang, H W ^d  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b Division of Cardiology   (Taiwan)

^c Division of Cardiovascular Surgery   (Canada)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Diabetes; Leg ischaemia; Stem cells

Indexed keywords

ADULT; AGED; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DIABETIC PATIENT; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; LEG ISCHEMIA; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; STEM CELL;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL CELLS; FEMALE; HUMANS; ISCHEMIA; LEG; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 60049084417     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02649.x     Document Type: Article

References (23)

1. Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 1999 103 : 1231 1236.
2. Risau W. Mechanisms of angiogenesis. Nature 1997 386 : 671 674.
3. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997 275 : 964 967.
4. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A et al. Evidence of circulating bone marrow-derived endothelial cells. Blood 1998 92 : 362 367.
5. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999 85 : 221 228.
6. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 1995 11 : 73 91.
7. Chen YH, Lin SJ, Lin FY, Wu TC, Tsao CR, Huang PH et al. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 2007 56 : 1559 1568.
8. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000 95 : 952 958.
9. Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000 95 : 3106 3112.
10. + haematopoietic stem cells. Ann N Y Acad Sci 2003 996 : 141 151.
11. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, Quyyumi AA et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003 348 : 593 600.
12. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001 103 : 2885 2890.
13. Spyridopoulos I, Haendeler J, Urbich C, Brummendorf TH, Oh H, Schneider MD et al. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation 2004 110 : 3136 3142.
14. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 2000 106 : 571 578.
15. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971 285 : 1182 1186.
16. Ito WD, Arras M, Scholz D, Wunkler B, Htun P, Schaper W. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol 1997 273 : H1255 H1265.
17. Risau W, Sariolas H, Zerwes HG, Sasse J, Ekblom P, Kemler R et al. Vasculogenesis and angiogenesis in embryonic stem cell-derived embryoid bodies. Development 1988 102 : 471 478.
18. Kalka C, Masuda H, Takahashi T, Kalka-Moll W, Silver M, Kearney M et al. Transplantation of ex-vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000 97 : 3422 3427.
19. Bahlmann FH, Groot KD, Mueller O, Hertel B, Haller H, Fliser D. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 2005 45 : 526 529.
20. Humpert PM, Djuric Z, Zeuge U, Oikonomou D, Seregin Y, Laine K et al. Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor-dependent signalling. Mol Med 2008 14 : 301 308.
21. Murphy C, Kanaganayagam GS, Jiang B, Chowienczyk PJ, Zbinden R, Saha M et al. Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. Arterioscler Thromb Vasc Biol 2007 27 : 936 942.
22. Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004 24 : 1246 1252.
23. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR et al. Human endothelial progenitor cells from Type II diabetes exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002 106 : 2781 2786.